Literature DB >> 7207205

Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type).

G M Tisi, A Conrique, E Barrett-Connor, S M Grundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7207205     DOI： 10.1016/0026-0495(81)90113-x

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  13 in total

1.  Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Jing Deng; Matthew Jaffa; Merit E Cudkowicz; Anne-Marie Wills
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

2.  Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India.

Authors:  Kamlesh Kumar Gupta; Jitendra Singh; Pradeep Gupta; M L Patel; Vivek Kumar; Shyam Chand Chaudhary
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Plasma and lipoprotein lipids and apolipoproteins AI, AII and B in patients with chronic airflow limitation.

Authors:  C H Bolton; E Mulloy; J Harvey; L G Downs; M Hartog
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

4.  Genetic variations in RORα are associated with chronic obstructive pulmonary disease.

Authors:  Yiming Yuan; Xiaoming Hou; Jinlong Zhang; Yulong Chen; Yulin Feng; Zhiguang Su
Journal:  J Hum Genet       Date:  2014-06-19       Impact factor: 3.172

5.  APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.

Authors:  Kristin M Burkart; Ani Manichaikul; Jemma B Wilk; Firas S Ahmed; Gregory L Burke; Paul Enright; Nadia N Hansel; Demondes Haynes; Susan R Heckbert; Eric A Hoffman; Joel D Kaufman; Jun Kurai; Laura Loehr; Stephanie J London; Yang Meng; George T O'Connor; Elizabeth Oelsner; Marcy Petrini; Tess D Pottinger; Charles A Powell; Susan Redline; Jerome I Rotter; Lewis J Smith; María Soler Artigas; Martin D Tobin; Michael Y Tsai; Karol Watson; Wendy White; Taylor R Young; Stephen S Rich; R Graham Barr
Journal:  Eur Respir J       Date:  2013-07-30       Impact factor: 16.671

6.  Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.

Authors:  Earl S Ford; Anne G Wheaton; David M Mannino; Letitia Presley-Cantrell; Chaoyang Li; Janet B Croft
Journal:  Respir Res       Date:  2012-12-13

7.  Relationships among smoking habits, airflow limitations, and metabolic abnormalities in school workers.

Authors:  Masafumi Horie; Satoshi Noguchi; Wakae Tanaka; Yasushi Goto; Hisanao Yoshihara; Masaki Kawakami; Masaru Suzuki; Yoshio Sakamoto
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

8.  The Effect of Statins on Blood Gene Expression in COPD.

Authors:  Ma'en Obeidat; Nick Fishbane; Yunlong Nie; Virginia Chen; Zsuzsanna Hollander; Scott J Tebbutt; Yohan Bossé; Raymond T Ng; Bruce E Miller; Bruce McManus; Stephen Rennard; Peter D Paré; Don D Sin
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

9.  Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.

Authors:  Lingling Wang; Yufu Tang; Shuo Liu; Shitao Mao; Yuan Ling; Dan Liu; Xiaoyu He; Xiaoge Wang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease.

Authors:  Beti Zafirova-Ivanovska; Jagoda Stojkovikj; Dejan Dokikj; Sasha Anastasova; Angela Debresliovska; Sead Zejnel; Dragana Stojkovikj
Journal:  Open Access Maced J Med Sci       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.